No Data
No Data
No Data
No Data
No Data
Virpax Announces Results of Maximum Tolerated Dose Study for Probudur
-Liposomal Formulation Developed to Provide Both Immediate and Sustained Pain Relief- Virpax Pharmaceuticals, Inc. ("Virpax" or the "Company") (NASDAQ:VRPX), a company specializing in developing non-addictive
BusinesswireApr 30 19:30
12 Health Care Stocks Moving In Thursday's After-Market Session
GainersBio-Path Hldgs (NASDAQ:BPTH) stock moved upwards by 9.0% to $4.58 during Thursday's after-market session. The company's market cap stands at $3.4 million. Biora Therapeutics (NASDAQ:BIOR) share
BenzingaApr 19 04:31
Virpax Pharmaceuticals to Offer Stock and Warrants
Virpax Pharmaceuticals to Offer Stock and Warrants
Dow JonesApr 19 04:25
12 Health Care Stocks Moving In Monday's Pre-Market Session
GainersLongeveron (NASDAQ:LGVN) shares moved upwards by 75.0% to $3.85 during Monday's pre-market session. The market value of their outstanding shares is at $9.6 million. PetVivo Hldgs (NASDAQ:PETV)
BenzingaApr 8 20:09
On April 2, Virpax Pharmaceuticals Inc Got Letter From Nasdaq Stating That Company Was Not In Compliance With Nasdaq Listing Rule
On April 2, Virpax Pharmaceuticals Inc Got Letter From Nasdaq Stating That Company Was Not In Compliance With Nasdaq Listing Rule
BenzingaApr 4 04:28
Virpax Pharmaceuticals' Settlement Strain: Risk of Stalled Development and Hindered Growth
TipRanksMar 27 14:01
No Data
No Data